🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 653942102 (prev. G6096M114 )
- Market Cap
- Micro Cap
- IPO
- 1/17/2018 · $15.80/share
- Previous Symbol
- APM (changed 6/22/2026)
- Previous Name
- Aptorum Group Ltd.
Business: Niki BioSolutions, Inc. is a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing a broad portfolio of projects under development of therapeutic and diagnostic technologies to tackle unmet medical needs.
Notes: January 20, 2023 -- a clinical stage biopharmaceutical company dedicated to tackling unmet medical needs in oncology, autoimmune and infectious diseases, today announced a 1-for-10 reverse stock split of the Company's Class A Ordinary Shares, effective at 12:01 a.m. Eastern Time on January 23, 2023. The Company’s Class A Ordinary Shares is expected to commence trading on a split-adjusted basis when the markets open on January 23, 2023. The Company’s Class B Ordinary Shares shall also be split on a 1-for-10 reverse basis. The Company's shares of Class A Ordinary Shares will continue to trade on the NASDAQ under the symbol "APM." The new CUSIP number for the Company's Class A Ordinary Shares post-reverse stock split is G6096M114.
Company Contact
- CEO
- Ian Huen
- CFO
- Wong Kwok Kuen
- Investor Relations
- Dave Gentry. Redchip Financial Communications · 407-491-4498 · info@nikibiosolutions.com